Daishi Tian
2 clinical trials · 2 recruiting · OTHER
Trials by Daishi Tian
RECRUITINGEarly Phase 1NCT07058298
GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis(24103)
This is a single-arm, open-label and early exploratory clinical study, with the purpose to study the safety, tolerability and initial clinical efficacy of GC012F Injection in the...
Sponsor: Daishi TianEnrolling: 61 location
Generalized Myasthenia Gravis (gMG)
RECRUITINGEarly Phase 1NCT07337785
CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases
This single-arm, open-label investigator-initiated trial (IIT) evaluates the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of RD06-05 in patients with...
Sponsor: Daishi TianEnrolling: 361 location
Relapsing or Refractory Multiple Sclerosis (MS)Myasthenia Gravis (MG)Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)+1